FINWIRES · TerminalLIVE
FINWIRES

SASE:4002

6 stories mentioning SASE:4002Updated 7d ago

Every FINWIRES story that references SASE:4002, newest first.

What are analysts saying about SASE:4002?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on SASE:4002?

Research

Arqaam Capital Reduces Mouwasat Medical Services' PT, Keeps at Buy

Arqaam Capital on Wednesday reduced the price target for hospital chain company Mouwasat Medical Services (SASE:4002) to 90.00 Saudi riyals from 98.00 riyals and affirmed its buy rating.

SASE:4002
Research

Al Rajhi Capital Cuts Mouwasat Medical Services PT, Keeps at Neutral

Al Rajhi Capital on Wednesday reduced the price target for hospital chain operator Mouwasat Medical Services (SASE:4002) to 72 Saudi riyals from 81 riyals, while reiterating its neutral rating.

SASE:4002
Research

Ubhar Capital Oman Cuts Mouwasat Medical Services' PT, Affirms at Buy

Ubhar Capital Oman on Thursday reduced the price target for hospital chain company Mouwasat Medical Services (SASE:4002) to 75.10 Saudi riyals from 90.00 riyals and kept its rating at buy.

SASE:4002
Research

HSBC Upgrades Mouwasat Medical Services to Hold, Lifts PT

HSBC on Tuesday raised hospital chain operator Mouwasat Medical Services (SASE:4002) to hold from reduce and increased its price target to 63 Saudi riyals from 61 riyals.

SASE:4002
Research

Citi Lowers Mouwasat Medical Services PT, Keeps Neutral Rating

Citi on Tuesday reduced the price target for hospital chain operator Mouwasat Medical Services (SASE:4002) to 75 Saudi riyals from 80 riyals, while reiterating its neutral rating.

SASE:4002
Research

HSBC Downgrades Mouwasat Medical Services to Reduce, Cuts PT

HSBC on Tuesday downgraded hospital chain operator Mouwasat Medical Services (SASE:4002) to reduce from hold and decreased its price target to 61 Saudi riyals from 76 riyals.

SASE:4002

Track with the FINWIRES app suite